Literature DB >> 12242346

Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration.

Lihua Y Marmorstein1, Francis L Munier, Yvan Arsenijevic, Daniel F Schorderet, Precious J McLaughlin, Daniel Chung, Elias Traboulsi, Alan D Marmorstein.   

Abstract

Malattia Leventinese (ML), an inherited macular degenerative disease, is closely reminiscent of age-related macular degeneration (AMD), the most common cause of incurable blindness. Both ML and AMD are characterized by extracellular deposits known as drusen between the retinal pigment epithelium (RPE) and Bruch's membrane. The mechanism underlying drusen formation is unknown. An Arg to Trp mutation in a gene of unknown function, EFEMP1, is responsible for ML, indicating EFEMP1 may be important in drusen formation. Here, we show that wild-type EFEMP1 is a secreted protein whereas mutant EFEMP1 is misfolded, secreted inefficiently, and retained within cells. In normal eyes, EFEMP1 is not present at the site of drusen formation. However, in ML eyes, EFEMP1 accumulates within the RPE cells and between the RPE and drusen, but does not appear to be a major component of drusen. Furthermore, in AMD eyes, EFEMP1 is found to accumulate beneath the RPE immediately overlaying drusen, but not in the region where there is no apparent retinal pathology observed. These data present evidence that misfolding and aberrant accumulation of EFEMP1 may cause drusen formation and cellular degeneration and play an important role in the etiology of both ML and AMD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12242346      PMCID: PMC130587          DOI: 10.1073/pnas.202491599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

Review 1.  Age-related macular degeneration.

Authors:  S L Fine; J W Berger; M G Maguire; A C Ho
Journal:  N Engl J Med       Date:  2000-02-17       Impact factor: 91.245

Review 2.  Risk factors for age-related macular degeneration.

Authors:  J R Evans
Journal:  Prog Retin Eye Res       Date:  2001-03       Impact factor: 21.198

Review 3.  Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases.

Authors:  M Y Sherman; A L Goldberg
Journal:  Neuron       Date:  2001-01       Impact factor: 17.173

4.  Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium.

Authors:  A D Marmorstein; L Y Marmorstein; M Rayborn; X Wang; J G Hollyfield; K Petrukhin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

5.  Impairment of the ubiquitin-proteasome system by protein aggregation.

Authors:  N F Bence; R M Sampat; R R Kopito
Journal:  Science       Date:  2001-05-25       Impact factor: 47.728

Review 6.  Protein disulfide isomerase: multiple roles in the modification of nascent secretory proteins.

Authors:  R B Freedman
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

7.  A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression.

Authors:  L Y Marmorstein; A V Kinev; G K Chan; D A Bochar; H Beniya; J A Epstein; T J Yen; R Shiekhattar
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

8.  Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

Authors:  B I Giasson; J E Duda; I V Murray; Q Chen; J M Souza; H I Hurtig; H Ischiropoulos; J Q Trojanowski; V M Lee
Journal:  Science       Date:  2000-11-03       Impact factor: 47.728

9.  Sequence, recombinant expression and tissue localization of two novel extracellular matrix proteins, fibulin-3 and fibulin-4.

Authors:  R Giltay; R Timpl; G Kostka
Journal:  Matrix Biol       Date:  1999-10       Impact factor: 11.583

Review 10.  Age-related macular degeneration.

Authors:  N M Bressler; S B Bressler; S L Fine
Journal:  Surv Ophthalmol       Date:  1988 May-Jun       Impact factor: 6.048

View more
  89 in total

Review 1.  Fibulins: physiological and disease perspectives.

Authors:  W Scott Argraves; Lisa M Greene; Marion A Cooley; William M Gallagher
Journal:  EMBO Rep       Date:  2003-12       Impact factor: 8.807

2.  Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration.

Authors:  Sudha K Iyengar; Danhong Song; Barbara E K Klein; Ronald Klein; James H Schick; Jennifer Humphrey; Christopher Millard; Rachel Liptak; Karlie Russo; Gyungah Jun; Kristine E Lee; Bonnie Fijal; Robert C Elston
Journal:  Am J Hum Genet       Date:  2003-12-19       Impact factor: 11.025

Review 3.  Genetic factors of age-related macular degeneration.

Authors:  Jingsheng Tuo; Christine M Bojanowski; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2004-03       Impact factor: 21.198

4.  Protein aggregation in retinal cells and approaches to cell protection.

Authors:  Irina Surgucheva; Natalia Ninkina; Vladimir L Buchman; Kenneth Grasing; Andrei Surguchov
Journal:  Cell Mol Neurobiol       Date:  2005-09       Impact factor: 5.046

5.  Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration.

Authors:  Sepideh Zareparsi; Kari E H Branham; Mingyao Li; Sapna Shah; Robert J Klein; Jurg Ott; Josephine Hoh; Gonçalo R Abecasis; Anand Swaroop
Journal:  Am J Hum Genet       Date:  2005-05-13       Impact factor: 11.025

6.  Retinal pigment epithelial cells synthesize laminins, including laminin 5, and adhere to them through alpha3- and alpha6-containing integrins.

Authors:  Sabine Aisenbrey; Minlei Zhang; Daniel Bacher; Jason Yee; William J Brunken; Dale D Hunter
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-12       Impact factor: 4.799

7.  Effect of rapamycin on the fate of P23H opsin associated with retinitis pigmentosa (an American Ophthalmological Society thesis).

Authors:  Shalesh Kaushal
Journal:  Trans Am Ophthalmol Soc       Date:  2006

8.  Unfolding the Therapeutic Potential of Chemical Chaperones for Age-related Macular Degeneration.

Authors:  Theodor Sauer; Mrinali Patel; Chi-Chao Chan; Jingsheng Tuo
Journal:  Expert Rev Ophthalmol       Date:  2008-02

9.  Reduced secretion of fibulin 5 in age-related macular degeneration and cutis laxa.

Authors:  Andrew J Lotery; Dominique Baas; Caroline Ridley; Richard P O Jones; Caroline C W Klaver; Edwin Stone; Tomoyuki Nakamura; Andrew Luff; Helen Griffiths; Tao Wang; Arthur A B Bergen; Dorothy Trump
Journal:  Hum Mutat       Date:  2006-06       Impact factor: 4.878

10.  Differential tolerance of 'pseudo-pathogenic' tryptophan residues in calcium-binding EGF domains of short fibulin proteins.

Authors:  Annie Nguyen; John D Hulleman
Journal:  Exp Eye Res       Date:  2014-12-03       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.